US 12162853
Synthesis of esuberaprost prodrugs
granted A61PA61P1/04A61P7/02
Quick answer
US patent 12162853 (Synthesis of esuberaprost prodrugs) held by United Therapeutics Corporation expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/04, A61P7/02